--The company may (or may not be) positioned for a sell-off. Members of the Board include Francisco Partners, who specialize in Divisional Buyouts.
--Benefits and PTO are "industry standard" or worse. If you have a high annual healthcare or prescription cost, probably look elsewhere.
--No CTO, or real direction on the tech side. Rapid acquisitions leads to a fragmented tech-space with a lot of politics taking the place of efficiency.
--Not a ton of transparency from the CEO. The "All-Staffs" are few and far between and don't address the future of the company. No talk of IPO, probably positioning for acquisition, but who knows? They don't tell us.
--I've never talked to my bosses' boss, which I find a bit strange. That's probably just poor leadership in my business unit though. No points deducted, just something to mention.